December 15, 2004

Speaker Biographies

John E. Calfee is a resident scholar at AEI. From 1980 to 1986, he served in the Bureau of Economics at the Federal Trade Commission. Mr. Calfee has taught marketing and consumer behavior in the business schools of the University of Maryland-College Park and Boston University, and he was a visiting senior fellow at the Brookings Institution. He is the author of Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Fear of Persuasion: A New Perspective on Advertising and Regulation (distributed by AEI Press, 1997).

Joseph A. DiMasi is the director of economic analysis at Tufts University Center for the Study of Drug Development. His research interests include the R&D cost of new drug development, clinical success and phase attrition rates, development times, changes in the structure and performance of the pharmaceutical and biotechnology industries, pricing and profitability in the pharmaceutical industry, and the role that pharmacoeconomic evaluations have played in the R&D process. He has served as a member of the Department of Economics at the College of the Holy Cross. He has authored numerous articles published in economics and medical research journals and served on the editorial boards of the Drug Information Journal and the Journal of Research in Pharmaceutical Economics.

Scott Gottlieb, M.D., is a physician and a resident fellow at AEI specializing in FDA and CMS regulatory policies, the development of new medical technology, and political and clinical trends in medicine. He is the author of the Forbes/Gottlieb Medical Technology Report and a staff  writer for the British Medical Journal. Dr. Gottlieb was senior adviser to the administrator at the Center for Medicare and Medicaid Services and director of medical policy development and senior adviser for medical technology to the commissioner at the Food and Drug Administration. He has served as the author of the Gilder Biotech Report and as the senior editor of “Pulse” in the Journal of the American Medical Association. Previously, Dr. Gottlieb worked as a health care analyst at Alex.Brown & Sons and was a medical internist at Stamford Hospital.

Alan Lyles is a pharmacist and the Henry A. Rosenberg Professor of Public, Private, and Nonprofit Partnerships in the School of Public Affairs’ Health Systems Management faculty at the University of Baltimore. He is a senior fellow in the Hoffberger Center for Professional Ethics and a senior fellow in the Center on Drugs and Public Policy at the University of Maryland’s School of Pharmacy. Mr. Lyles was on the Department of Health Policy and Management’s faculty at the Johns Hopkins Bloomberg School of Public Health, where he now holds an adjunct faculty appointment. He has been assistant dean in the Johns Hopkins University School of Medicine, chair of the Maryland Drug Use Review Board, and chair of the Association of American Medical Colleges Group on Institutional Planning. He coedits the pharmaceutical economics and health policy section of Clinical Therapeutics. Mr. Lyles has testified before the Maryland House Economic Matters and Environmental Matters Committees and the U.S. Senate Finance Committee.

View event detail